“…Recently, our group reported a synthetic strategy enabling the incorporation of bicyclic scaffolds as peptide constraints during traditional peptide synthesis. The synthesis of bridged 6-oxa-3,8-diazabicyclo[3.2.1]octan-2-ones [ 31 ], fused tetrahydropyrazino[2,1- b ][1,3]oxazine-4,7(6 H ,8 H )-diones X (X = O, n = 1) [ 32 ], hexahydro-4 H -pyrazino[1,2- a ]pyrimidine-4,7(6 H )-diones X (X = NR 3 , n = 1) [ 32 ] and hexahydropyrimido[1,2- d ][ 1 , 4 ]diazepine-4,7(1 H ,6 H )-diones X (X = NR 3 , n = 2) [ 33 ] were performed via westbound direction (towards the amino terminus) N -acyliminium cyclization–nucleophilic addition with Ser, Thr and 2,4-diaminobutyric acid as the sources of oxygen, sulfur and nitrogen nucleophiles, respectively. The solid-phase synthesis of tetrahydro-2 H -oxazolo[3,2-a]pyrazine-5(3 H )-ones IV (R 2 = H) [ 34 ] was carried out via eastbound direction (towards the carboxyl terminus) cyclization, and the scope of this synthetic strategy was expanded recently to yield [7,8,9 + 5]-fused rings from Ser, Cys and C-nucleophiles (structure XI ) [ 13 ].…”